|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 26 studies with search of: | Open Studies | "Whooping Cough" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
|
||||
| 2 | Recruiting |
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines
|
||||
| 3 | Recruiting |
Survey for Usage Rates of Pertussis Vaccines in the State of Wisconsin
|
||||
| 4 | Recruiting |
Study of QUADRACEL® Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
|
||||
| 5 | Recruiting |
Post Marketing Surveillance for ADACEL™ in South Korea
|
||||
| 6 | Recruiting |
Regulatory Post-Marketing Surveillance Study for TETRAXIM™
|
||||
| 7 | Recruiting |
Database Surveillance Safety Study of PENTACEL® Vaccine
|
||||
| 8 | Recruiting |
Montelukast for Persistent Cough in Young People and Adults
|
||||
| 9 | Recruiting |
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China
|
||||
| 10 | Recruiting |
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
|
||||
| 11 | Recruiting |
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
|
||||
| 12 | Recruiting |
Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia
|
||||
| 13 | Unknown † |
Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
|
||||
| 14 | Not yet recruiting |
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
|
||||
| 15 | Recruiting |
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year-old Adolescents
|
||||
| 16 | Recruiting |
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants.
|
||||
| 17 | Recruiting |
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
|
||||
| 18 | Unknown † |
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
|
||||
| 19 | Recruiting |
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
|
||||
| 20 | Recruiting |
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-26) |
|